Psoriasis Therapeutics - Global Market Outlook (2017-2026)

  • ID: 4480569
  • Report
  • Region: Global
  • 170 pages
  • Stratistics Market Research Consulting Pvt Ltd
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca
  • Celgene Corporation
  • Eli Lilly and Company
  • Janssen Biotech Inc.
  • LEO Pharma A/S
  • MORE
According to the publisher, the Global Psoriasis Therapeutics market is expected to grow at a CAGR of 10.5% during the forecast period. Availability of new diagnostic procedures, growing preference for combination therapies, increasing awareness about treatment, rising demand for improved healthcare infrastructure and changing lifestyle of people are some factors influencing the market growth. Further, better diagnostic tools availablity for psoriasis will result in increasing the treatmento seeking patient population which in turn boost the market’s growth prospects in the coming years.

Psoriasis is a lifelong auto immune disease characterized by patches of abnormal skin. It usually thought to be a genetic disease that is triggered by environmental factors. There is n-cure for psoriasis however, a variety of treatments can assist control the sympto ms. It varies in severity from small, localized patches to complete body coverage. These skin patches are usually red, itchy, and scaly. Living in moist humid climate appears to delay the condition for appearing. Dry arid climates seem to aggravate the condition. Washing with Psoriasis removes the dry skin, but then the skin underneath is raw. Hard water appears to worsen the condition in dry climates, but not as much in humid areas. Soft water appears better.

Depending on molecule, biologics segment dominated the market. This segment comprises medicinal products extracted from biological sources such as humans, animals, or microorganisms and manufactured biotechnologically using the latest technologies. Unlike synthesized drugs, they have a complex structure and are not easily identified or characterized. Biologics include products, such as enzymes, allergens, blood and blood components, gene therapy, recombinant proteins, somatic cells, tissues, and vaccines. The growth of this segment is also attributed the launch of novel biologics like Cosentyx by Novartis. By geography, North America dominated the global market due the established healthcare infrastructure, high adoption of therapeutics and presence of key manufacturers in the U.S are a few factors responsible for its large share. Moreover, increasing prevalence and favorable government initiatives are some drivers fueling the market growth.

Some of the key players in the global Psoriasis Therapeutics market Johnson & Johnson, Novartis AG, Merck & Co. Inc., Janssen Biotech Inc., Incyte Corp., Eli Lilly and Company, Eisai Co. Ltd., Celgene Corporation, Bristo l Myers Squibb Co., AstraZeneca, Amgen, Inc., AbbVie Inc., LE-Pharma A/S, UCB S.A and Pfizer Inc.

Dosage Forms Covered:
  • Liquid
  • Solid
  • Semi-solid
  • Molecule Covered:
  • Small Molecules
  • Biologics
Mechanism of Actions Covered:
  • IL blocker
  • PDE4 Inhibito rs
  • TNF Inhibito rs
  • Other Mechanism of Actions
Route of Administrations Covered:
  • top ical
  • Oral
  • Parenteral
Distribution Channels Covered:
  • Retail Pharmacy
  • Online Sales
  • Hospital Pharmacy
  • Other Distribution Channels
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What our report offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

A Datapack/Market Engineering Excel Sheet is provided for free with the purchase of the Report format Enterprisewide.  A Datapack/Market Engineering Excel Sheet is provided for free with the purchase of the Report format Enterprisewide. 
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca
  • Celgene Corporation
  • Eli Lilly and Company
  • Janssen Biotech Inc.
  • LEO Pharma A/S
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Psoriasis Therapeutics Market, By Dosage Form
5.1 Introduction
5.2 Liquid
5.3 Solid
5.4 Semi-solid

6 Global Psoriasis Therapeutics Market, By Molecule
6.1 Introduction
6.2 Small Molecules
6.3 Biologics

7 Global Psoriasis Therapeutics Market, By Mechanism of Action
7.1 Introduction
7.2 IL blocker
7.3 PDE4 Inhibitors
7.4 TNF Inhibitors
7.5 Other Mechanism of Actions

8 Global Psoriasis Therapeutics Market, By Route of Administration
8.1 Introduction
8.2 Topical
8.3 Oral
8.4 Parenteral

9 Global Psoriasis Therapeutics Market, By Distribution Channel
9.1 Introduction
9.2 Retail Pharmacy
9.3 Online Sales
9.4 Hospital Pharmacy
9.5 Other Distribution Channels

10 Global Psoriasis Therapeutics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Johnson & Johnson
12.2 Novartis AG
12.3 Merck & Co. Inc.
12.4 Janssen Biotech Inc.
12.5 Incyte Corp.
12.6 Eli Lilly and Company
12.7 Eisai Co. Ltd.
12.8 Celgene Corporation
12.9 Bristol Myers Squibb Co.
12.10 AstraZeneca
12.11 Amgen, Inc.
12.12 AbbVie Inc.
12.13 LEO Pharma A/S
12.14 UCB S.A
12.15 Pfizer Inc.

List of Tables
Table 1 Global Psoriasis Therapeutics Market Outlook, By Region (2016-2026) (US$ MN)
Table 2 Global Psoriasis Therapeutics Market Outlook, By Dosage Form (2016-2026) (US$ MN)
Table 3 Global Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
Table 4 Global Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
Table 5 Global Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
Table 6 Global Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
Table 7 Global Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
Table 8 Global Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
Table 9 Global Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
Table 10 Global Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
Table 11 Global Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
Table 12 Global Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
Table 13 Global Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
Table 14 Global Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
Table 15 Global Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
Table 16 Global Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
Table 17 Global Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
Table 18 Global Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
Table 19 Global Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
Table 20 Global Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
Table 21 Global Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
Table 22 North America Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
Table 23 North America Psoriasis Therapeutics Market Outlook, By Dosage Form (2016-2026) (US$ MN)
Table 24 North America Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
Table 25 North America Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
Table 26 North America Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
Table 27 North America Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
Table 28 North America Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
Table 29 North America Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
Table 30 North America Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
Table 31 North America Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
Table 32 North America Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
Table 33 North America Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
Table 34 North America Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
Table 35 North America Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
Table 36 North America Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
Table 37 North America Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
Table 38 North America Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
Table 39 North America Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
Table 40 North America Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
Table 41 North America Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
Table 42 North America Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
Table 43 Europe Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
Table 44 Europe Psoriasis Therapeutics Market Outlook, By Dosage Form (2016-2026) (US$ MN)
Table 45 Europe Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
Table 46 Europe Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
Table 47 Europe Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
Table 48 Europe Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
Table 49 Europe Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
Table 50 Europe Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
Table 51 Europe Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
Table 52 Europe Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
Table 53 Europe Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
Table 54 Europe Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
Table 55 Europe Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
Table 56 Europe Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
Table 57 Europe Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
Table 58 Europe Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
Table 59 Europe Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
Table 60 Europe Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
Table 61 Europe Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
Table 62 Europe Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
Table 63 Europe Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
Table 64 Asia Pacific Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
Table 65 Asia Pacific Psoriasis Therapeutics Market Outlook, By Dosage Form (2016-2026) (US$ MN)
Table 66 Asia Pacific Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
Table 67 Asia Pacific Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
Table 68 Asia Pacific Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
Table 69 Asia Pacific Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
Table 70 Asia Pacific Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
Table 71 Asia Pacific Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
Table 72 Asia Pacific Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
Table 73 Asia Pacific Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
Table 74 Asia Pacific Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
Table 75 Asia Pacific Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
Table 76 Asia Pacific Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
Table 77 Asia Pacific Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
Table 78 Asia Pacific Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
Table 79 Asia Pacific Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
Table 80 Asia Pacific Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
Table 81 Asia Pacific Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
Table 82 Asia Pacific Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
Table 83 Asia Pacific Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
Table 84 Asia Pacific Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
Table 85 South America Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
Table 86 South America Psoriasis Therapeutics Market Outlook, By Dosage Form (2016-2026) (US$ MN)
Table 87 South America Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
Table 88 South America Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
Table 89 South America Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
Table 90 South America Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
Table 91 South America Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
Table 92 South America Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
Table 93 South America Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
Table 94 South America Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
Table 95 South America Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
Table 96 South America Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
Table 97 South America Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
Table 98 South America Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
Table 99 South America Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
Table 100 South America Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
Table 101 South America Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
Table 102 South America Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
Table 103 South America Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
Table 104 South America Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
Table 105 South America Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
Table 106 Middle East Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
Table 107 Middle East Psoriasis Therapeutics Market Outlook, By Dosage Form (2016-2026) (US$ MN)
Table 108 Middle East Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
Table 109 Middle East Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
Table 110 Middle East Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
Table 111 Middle East Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
Table 112 Middle East Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
Table 113 Middle East Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
Table 114 Middle East Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
Table 115 Middle East Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
Table 116 Middle East Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
Table 117 Middle East Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
Table 118 Middle East Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
Table 119 Middle East Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
Table 120 Middle East Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
Table 121 Middle East Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
Table 122 Middle East Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
Table 123 Middle East Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
Table 124 Middle East Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
Table 125 Middle East Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
Table 126 Middle East Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Johnson & Johnson
Novartis AG
Merck & Co. Inc.
Janssen Biotech Inc.
Incyte Corp.
Eli Lilly and Company
Eisai Co. Ltd.
Celgene Corporation
Bristol Myers Squibb Co.
AstraZeneca
Amgen, Inc.
AbbVie Inc.
LEO Pharma A/S
UCB S.A
Pfizer Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll